Assistant Professor
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Dr. Ahn is Assistant Professor at Dana-Farber Cancer Institute and Harvard Medical School who specializes in chronic lymphocytic leukemia (CLL). Despite significant advances made in the field, CLL patients continue to have heterogeneous outcomes and frequently develop drug resistance against targeted agents. Her research focuses on genomic analysis to improve the identification of high-risk CLL and the development of novel treatment strategies that can overcome treatment resistance.
Who Becomes/Are Double Refractory Patients?
Sunday, September 14, 2025
09:25 - 09:40 CEST
